Production (Stage)
HCW Biologics Inc.
HCWB
$5.49
-$0.09-1.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -98.71% | -7.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -98.71% | -7.41% | |||
| Cost of Revenue | -98.70% | -7.42% | |||
| Gross Profit | -98.73% | -7.39% | |||
| SG&A Expenses | -28.46% | 34.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.20% | 17.92% | |||
| Operating Income | 11.08% | -20.86% | |||
| Income Before Tax | 34.87% | 13.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 34.87% | 13.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.87% | 13.56% | |||
| EBIT | 11.08% | -20.86% | |||
| EBITDA | 6.10% | -6.05% | |||
| EPS Basic | 98.46% | 22.71% | |||
| Normalized Basic EPS | 97.87% | -7.08% | |||
| EPS Diluted | 98.46% | 22.71% | |||
| Normalized Diluted EPS | 97.87% | -7.08% | |||
| Average Basic Shares Outstanding | 4,124.65% | 11.83% | |||
| Average Diluted Shares Outstanding | 4,124.65% | 11.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||